The Top UAT Mistakes Sponsors Make in Clinical Trials—and How to Avoid Them
By Krisanne Flynn
Lead Consultant,
eClinical Systems and UAT Services, CSC
Clinical trials run on data, but that data depends on systems working exactly as intended. User Acceptance Testing (UAT) is designed to confirm that a system is ready for use. But readiness depends on how UAT is approached. When testing is limited to standard workflows or expected outcomes, it may confirm that a clinical trial system, such as eCOA or IRT, works as built—without fully challenging how it will perform in the realities of a live study.
As a result, gaps often emerge during enrollment, protocol changes, or inspections, when resolving them is far more complex and costly.
Below are the top UAT mistakes that clinical trial sponsors often make, with tips on how to avoid them.
1. Treating UAT as a Formality Instead of a Protocol-Aligned Risk Control
UAT is often approached as a required milestone before go-live, with scenarios derived from system requirements intended to align with the protocol. But in practice, gaps can emerge when those requirements are translated into test cases that validate functionality without fully reflecting how the study will operate. The result is a disconnect between what was tested and how the system is expected to perform during real study execution. Testing may confirm the system works, but not that the study will work as designed.
The shift is simple but important:
UAT is not about confirming the system works—it’s about confirming the study will work.
How to avoid it:
Anchor UAT in both protocol execution and risk. Ensure scenarios trace back to requirements and accurately reflect real-world study workflows, including dosing logic, visit schedules, endpoints, and cross-system interactions. Identify Critical-to-Quality factors and prioritize testing around what most directly impacts patient safety, data integrity, and study outcomes.
2. Relying on Vendor-Written UAT Scripts
It’s common for sponsors to rely on vendors to develop UAT scripts for the systems they build. Vendor-provided scripts are often designed to confirm that the system behaves as configured, not to independently assess whether it supports real-world protocol execution. When sponsors rely on these scripts without modification or additional testing, meaningful study risks may go unchallenged.
On paper, the system passes. In reality, risks remain hidden.
How to avoid it:
Sponsors can develop scripts internally, but this often places a significant burden on smaller teams. Leveraging experienced third-party experts reduces that strain while strengthening the rigor and independence of UAT.
3. Overlooking Real-World and Negative Scenarios
Many UAT approaches focus heavily on “happy path” testing, validating that the system works as expected under ideal conditions. But clinical trials don’t operate that way. Patients miss visits. Sites enter incorrect data. Protocol deviations occur. Systems must be tested for how they behave when things go wrong, not just when everything goes right.
How to avoid it:
Incorporate real-world and negative scenario testing. Simulate how systems behave under stress, across patient interactions, site workflows, and unexpected conditions.
4. Treating UAT as a One-Time Event
UAT is often treated as something that happens before go-live, and then ends. In reality, clinical trials evolve. Protocol amendments, system updates, and operational changes introduce new risks that must be validated. Without ongoing oversight, issues can emerge mid-study with limited ability to respond.
How to avoid it:
Build UAT into the full study lifecycle. Incorporate re-testing strategies, maintain oversight, and continuously monitor system performance.
The Bottom Line with UAT for Clinical Trial Systems
UAT isn’t about checking boxes, it’s about reducing risk before it reaches live study conduct. Sponsors that approach UAT as a strategic, risk-based discipline are better positioned to protect timelines, data integrity, and patient outcomes.
Want to pressure-test your UAT Approach? Let’s chat to assess your readiness and identify potential gaps before they impact your study. With CSC’s expert-led approach, every test is an opportunity to protect your trial’s supply chain and your reputation.